Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

CEP97 Activators

CEP97 activators are a diverse set of chemical compounds that indirectly enhance the functional activity of CEP97 through a variety of cellular signaling pathways, each playing a distinct role in cellular processes such as microtubule organization, centrosome cohesion, and cell cycle progression. Compounds like Forskolin, Rolipram, and IBMX elevate intracellular cAMP levels, subsequently activating protein kinase A (PKA). PKA is known to phosphorylate various substrates, and although not directly linked to CEP97 phosphorylation, this cascade is likely to enhance CEP97's activity in organizing microtubules and maintaining centrosome integrity. Similarly, lithium and SB216763 inhibit GSK-3 leading to increased beta-catenin levels, potentially stabilizing and augmenting CEP97's role within the centrosome. Furthermore, cell cycle regulators such as PD0332991 and MLN8237, which are inhibitors of CDK4/6 and Aurora A kinase, respectively, may indirectly boost CEP97 function by modulating processes critical for centrosome duplication and separation.

Other chemicals work by influencing mitotic spindle checkpoints and stress response pathways, which are crucial for the proper functioning of CEP97 during cell cycledivision. ZM447439, as an Aurora kinase inhibitor, and U0126, an MEK inhibitor, may indirectly promote CEP97's activity by affecting the mitotic spindle formation and the MEK/ERK signaling pathway, respectively. The inhibition of stress-related JNK signaling by SP600125 could shift cellular responses in a way that favors CEP97's role in centrosome integrity. In the realm of cytoskeletal dynamics, Y-27632's inhibition of ROCK potentially contributes to enhanced CEP97 function by influencing the positioning of centrosomes and orientation of the spindle apparatus. Lastly, Niclosamide, by altering the cellular energy state through the uncoupling of oxidative phosphorylation, might affect CEP97's activity related to cell cycle regulation and centrosome function. Collectively, these activators, through their targeted effects on various biochemical pathways, contribute to the enhancement of CEP97-mediated processes crucial for cell cycle progression and centrosome dynamics, highlighting the intricate network of regulation in which CEP97 operates.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. The elevated cAMP activates PKA, which can phosphorylate CEP97, thereby enhancing its role in the centrosome and affecting cell cycle progression.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels. This, in turn, activates PKA, potentially phosphorylating CEP97 and augmenting its activity in microtubule organization.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of phosphodiesterases, raising cAMP levels and subsequently activating PKA. This may result in enhanced phosphorylation of CEP97, thus promoting its role in centrosome cohesion.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium inhibits GSK-3, which can lead to the activation of Wnt signaling. Through this pathway, beta-catenin is stabilized, which could indirectly enhance the stabilization and activity of CEP97 in centrosome dynamics.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

SB216763 is a GSK-3 inhibitor, potentially increasing beta-catenin levels and indirectly enhancing CEP97 activity through improved centrosome function and microtubule stabilization.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

MLN8237 is an Aurora A kinase inhibitor. By inhibiting Aurora A, the compound could modulate centrosome maturation and separation, processes in which CEP97 is implicated, thus indirectly enhancing CEP97 activity.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM447439 is an Aurora kinase inhibitor. By inhibiting Aurora kinases, CEP97's role in centrosome dynamics could be indirectly enhanced by affecting the mitotic spindle formation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which may lead to changes in cellular stress responses and indirectly enhance the function of CEP97 in maintaining centrosome integrity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor, potentially altering cytoskeletal dynamics. This can indirectly enhance CEP97 activity by affecting centrosome positioning and spindle orientation.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$38.00
$79.00
$188.00
$520.00
$1248.00
$5930.00
8
(1)

Niclosamide uncouples oxidative phosphorylation, which can lead to changes in cellular energy states. This might indirectly enhance CEP97 activity by affecting its role in cell cycle regulation and centrosome function.